UC Davis Comprehensive Cancer Center has been recognized as a GO2 for Lung Cancer Center of Excellence, highlighting its strong commitment to high-quality, patient-centered lung cancer care for the region.

Each year, nearly 230,000 Americans are diagnosed with lung cancer and many learn of their diagnosis only after the disease has advanced. This late detection is a reason lung cancer remains the leading cause of cancer deaths in the United States. But there is good news: Low-dose CT screening can find lung cancer early — when it is most treatable and even curable.

This national designation recognizes the cancer center for following evidence-based screening guidelines, providing coordinated follow-up care and supporting patients through every step of the screening and treatment process.

“We are proud to have UC Davis Comprehensive Cancer Center join the community of GO2 for Lung Cancer Centers of Excellence that is national in scope and local in impact,” said GO2 Chief Healthcare Delivery Officer Joelle Fathi. “Through the GO2 COE network of community hospitals, clinics, and academic and VA medical centers, we are fostering and supporting essential knowledge sharing and collaboration that brings national and global advancements in early detection, treatment and care close to home.”